Molecular Profiles is now Juniper Pharma Services

Molecular Profiles has announced that the company is to adopt Juniper Pharma Services as its new brand name from 13 April 2015.

The move has coincided with its Boston-based parent company Columbia Laboratories, Inc. adopting its new brand identity as Juniper Pharmaceuticals, Inc., effective Monday, 31 April 2015, on which date its common stock began trading on the Nasdaq Stock Exchange under the new ticker symbol — “JNP”.

A new corporate website, reflecting the Juniper brand identity, has been launched at www.juniperpharma.com

Its new logo includes an icon featuring two interlocked rings, which symbolise the synergies between Juniper’s proprietary women’s health R&D program and contract pharmaceutical development expertise at Juniper Pharma Services.  

Nikin Patel, president at Juniper Pharma Services, said: “The single Juniper brand formalizes the experience and capabilities that has been built in Boston and Nottingham. The name change also coincides with the expansion of our service offering to the North American market.

“As we move forward under the Juniper brand, we remain committed to addressing the needs and challenges of the companies that rely on our contract pharmaceutical development and manufacturing services.”